The Local Switzerland

Actelion to appeal damages order

Wed, 04 May 2011 11:26:00 +0200

Swiss biotechnology group Actelion said Wednesday that it would appeal against $547 million in damages awarded by a California court to Japanese company Asahi Kasei Pharma.

Swiss biotech firm faces big bill after US lawsuit

Mon, 02 May 2011 17:44:00 +0200

Swiss biotech group Actellion has been told by a US court that it will have to pay a Japanese company up to $547 million over a cancelled contract.